Xcout Intel
Orthofix Medical Inc.
Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.
Subscribe to see Orthofix Medical Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Orthofix Medical Inc. at a glance
Orthofix Medical Inc. is a medical devices company headquartered in Lewisville, United States. It is publicly listed (OFIX) with a market capitalisation of $375.1M. Xcout tracks 20 named people at Orthofix Medical Inc., including Massimo Calafiore (President, Chief Executive Officer & Director).
Orthofix Medical Inc. leadership
- Massimo CalafiorePresident, Chief Executive Officer & Director
- Patrick FisherPresident of Global Biologics & Limb Reconstruction
- Aviva McPherronPresident of Global Operations & Quality
- Julie AndrewsChief Financial Officer
- J. Andres CedronChief Legal Officer & Corporate Secretary
- Geoffrey C. GillespieChief Accounting Officer
14 more named people on record for Orthofix Medical Inc., with roles, board committees and tenure — see the full roster →
Orthofix Medical Inc. competitors
A few of Orthofix Medical Inc.'s closest competitors — see the full list of competitors and alternatives →
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy. Among its offerings is EpiFix, a semi-permeable membrane designed to act as a protective barrier, effectively treating persistent wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores. Another key product is AmnioFix, a protective, semi-permeable allograft made from dehydrated human amnion/chorion membrane, utilized to aid post-surgical recovery. EpiCord and AmnioCord, both derived from dehydrated human umbilical cord, function as allografts that foster a protective healing environment and are applied in both advanced wound care and surgical recovery contexts. AMNIOBURN is also a semi-permeable protective allograft specifically developed for managing partial and full-thickness burn injuries. Its flagship product, mdHACM, is a micronized, powdered version of AMNIOFIX. These products predominantly find use in healthcare sectors like wound management, burn treatment, surgical procedures, and non-operative sports medicine. Additionally, the company supplies allografts for dental uses to other manufacturers on an original equipment manufacturer (OEM) basis. Distribution of its products primarily occurs within the United States, facilitated by its own sales teams, independent agents, and various independent distributors. MiMedx Group, Inc.'s main office is located in Marietta, Georgia.
Purgo Scientific is a medical device company that develops localized, sustained drug delivery devices designed to treat orthopedic biofilm infections and fracture-related infections. Their lead preclinical product, the Purgo Pouch, is a combination product intended to sustain local antibiotic therapy, kill biofilms, and expedite wound healing.
ORTHOREBIRTH Co., Ltd. is a Japanese medical and research corporation headquartered in Yokohama, Kanagawa-ken, Japan. The company applies advanced microfiber technology to develop innovative regenerative medical products, including cotton-shaped bone regeneration materials and artificial bone fillers like ReBOSSIS-MT.
Cerapedics Inc. is headquartered in Westminster, Colorado, United States, and develops orthopedic biologics and bone graft products.
Orthoson develops a micro-invasive bio-structural gel designed to treat lower back pain and degenerative disc disease by restoring the mechanical and biological function of intervertebral discs. The injectable treatment targets patients suffering from disc degeneration, aiming to provide immediate pain relief and restore a healthy disc environment.
Colorado Therapeutics LLC is a medical device company that develops proprietary cross-linked tissue products and biologic implants for soft tissue repair. The company serves the medical and healthcare sector by providing advanced technological solutions for surgical applications.
Get Orthofix Medical Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Orthofix Medical Inc. in Xcout Intel
- 20 named people with titles, LinkedIn and board committees
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access